News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
26,839 Results
Type
Article (1009)
Company Profile (1)
Press Release (25829)
Section
Business (6348)
Career Advice (2)
Deals (1122)
Drug Delivery (1)
Drug Development (4065)
Employer Resources (3)
FDA (1551)
Job Trends (624)
News (13295)
Policy (1124)
Tag
Academia (108)
Alliances (1381)
Alzheimer's disease (82)
Approvals (1554)
Artificial intelligence (1)
Autoimmune disease (1)
Bankruptcy (5)
Best Places to Work (586)
Biosimilars (6)
Biotechnology (1)
Bladder cancer (3)
Brain cancer (1)
Breast cancer (6)
Cancer (62)
Cardiovascular disease (21)
Career advice (2)
Cell therapy (11)
Cervical cancer (1)
Clinical research (3378)
Collaboration (18)
COVID-19 (54)
CRISPR (1)
C-suite (4)
Data (94)
Depression (2)
Diabetes (10)
Diagnostics (124)
Drug discovery (3)
Drug pricing (2)
Duchenne muscular dystrophy (1)
Earnings (2881)
Employer resources (3)
Events (3713)
Executive appointments (12)
FDA (1632)
Funding (17)
Gene editing (3)
Gene therapy (3)
GLP-1 (9)
Government (92)
Guidances (2)
Healthcare (641)
Immunology and inflammation (3)
Indications (1)
Infectious disease (55)
Inflammatory bowel disease (2)
Intellectual property (1)
IPO (408)
Job creations (75)
Job search strategy (2)
Kidney cancer (1)
Layoffs (4)
Legal (219)
Liver cancer (8)
Lung cancer (13)
Management (2)
Manufacturing (7)
MASH (3)
Medical device (1619)
Medtech (1619)
Mergers & acquisitions (724)
Metabolic disorders (13)
Multiple sclerosis (2)
NASH (2)
Neurodegenerative disease (1)
Neuroscience (90)
NextGen: Class of 2025 (178)
Non-profit (124)
Northern California (91)
Opinion (2)
Pain (4)
Pancreatic cancer (2)
Parkinson's disease (1)
Partnered (3)
Patents (13)
Patient recruitment (9)
People (1790)
Phase I (885)
Phase II (1508)
Phase III (1202)
Pipeline (40)
Postmarket research (179)
Preclinical (387)
Prostate cancer (1)
Radiopharmaceuticals (4)
Rare diseases (10)
Real estate (123)
Recruiting (1)
Regulatory (892)
Reports (2)
Research institute (88)
Schizophrenia (2)
Series A (2)
Series B (3)
Sickle cell disease (5)
Southern California (38)
Startups (136)
United States (812)
Vaccines (6)
Webinars (3)
Weight loss (1)
Date
Today (9)
Last 7 days (41)
Last 30 days (133)
Last 365 days (1380)
2025 (268)
2024 (1351)
2023 (1553)
2022 (2105)
2021 (2020)
2020 (1841)
2019 (1597)
2018 (1267)
2017 (1366)
2016 (1194)
2015 (1558)
2014 (1306)
2013 (992)
2012 (1100)
2011 (1150)
2010 (1125)
Location
Africa (8)
Alabama (1)
Arizona (14)
Asia (1676)
Australia (257)
California (177)
Canada (60)
China (12)
Colorado (7)
Delaware (9)
Europe (2900)
Florida (58)
Georgia (8)
Idaho (1)
Illinois (15)
India (1)
Indiana (3)
Japan (6)
Kansas (8)
Maryland (18)
Massachusetts (150)
Michigan (6)
Minnesota (35)
Missouri (5)
Nevada (5)
New Hampshire (2)
New Jersey (93)
New Mexico (1)
New York (65)
North Carolina (77)
Northern California (91)
Ohio (8)
Oklahoma (1)
Oregon (2)
Pennsylvania (29)
Puerto Rico (1)
South America (16)
South Carolina (2)
Southern California (38)
Tennessee (1)
Texas (28)
Utah (6)
Virginia (2)
Washington D.C. (1)
Washington State (10)
West Virginia (1)
26,839 Results for "cagent vascular".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion
March 5, 2025
·
2 min read
Press Releases
Cagent Vascular Initiates the Serranator® POINT FORCE Observational Registry
January 28, 2025
·
2 min read
Pharm Country
Cagent Vascular Raises $30 Million Series C Financing
Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, announced a Series C Financing close in excess of $30M. U.S. Venture Partners, led the round.
February 20, 2024
·
3 min read
Press Releases
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
A growing body of clinical evidence supports the use of Firefly’s FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia
March 6, 2025
·
10 min read
Pharm Country
Cagent Vascular announces initial RECOIL Study results: Serranator demonstrates 49% less recoil than POBA in BTK arteries
Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee RECOIL study.
July 11, 2023
·
4 min read
Press Releases
CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter
October 2, 2024
·
2 min read
Pharm Country
Cagent Vascular announces superior lumen gain, greater volumetric blood flow using Serration Angioplasty: A sub-analysis of the PRELUDE BTK study
Cagent Vascular, the exclusive developer of Serration Angioplasty (Serranator®), announced the results of a comparative sub-analysis of the PRELUDE-Below-the-Knee (BTK) study versus Plain Old Balloon Angioplasty (POBA).
January 31, 2023
·
4 min read
Press Releases
Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma
February 26, 2025
·
10 min read
Pharm Country
Cagent Vascular Announces Commercial Launch of the Serranator Above-the-Knee (ATK) Product
Cagent Vascular Inc., a developer of next generation angioplasty balloons using serration technology, announced the expansion of its product offering to include larger balloons to treat superficial femoral and popliteal arteries in the Above-the-Knee (ATK) segment.
June 1, 2022
·
3 min read
Press Releases
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular
January 13, 2025
·
2 min read
1 of 2,684
Next
